©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 112981
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112981
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112981
Figure 5 Graph illustrating the calibration plots for a prognostic model.
A: Calibration plots for the training set 3-month progression-free survival (PFS); B: Calibration plots for the validation set 3-month PFS; C: Calibration plots for the training set 6-month PFS; D: Calibration plots for the validation set 6-month PFS; E: Calibration plots for the training set 12-month overall survival (OS); F: Calibration plots for the validation set 12-month OS; G: Calibration plots for the training set 15-month OS; H: Calibration plots for the validation set 15-month OS; I: Calibration plots for the training set 18-month OS; J: Calibration plots for the validation set 18-month OS.
- Citation: Yao ZY, Bao G, Li GC, Hao QL, Ma LJ, Rao YX, Xu K, Ma X, Han ZX. Survival prognosis in advanced HER-2 negative gastric cancer treated with immunochemotherapy: A novel model. World J Gastrointest Oncol 2025; 17(11): 112981
- URL: https://www.wjgnet.com/1948-5204/full/v17/i11/112981.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.112981